Daniel M. Bollag

Daniel M. Bollag, Ph.D. has served as our Senior Vice President of Regulatory Affairs and Quality since January 2009. He previously served as Vice President, Regulatory Affairs, for Genzyme Corporation from 2006 to 2008.

From 2002 to 2006, Daniel Bollag held multiple positions at Sanofi-Aventis Pharmaceuticals, including Associate Vice President, Global Regulatory Domain Head, Associate Vice President, Global Regulatory Therapeutic Area Head, and Director, U.S. Regulatory Liaison. Daniel Bollag also served as Director, Project Planning and Management at the Bristol-Myers Squibb Pharmaceutical Research Institute from 2000 to 2002. Earlier in his career, from 1991-2000, he held positions at Merck Research Laboratories including Senior Project Manager, Project Planning and Management, Project Manager, and Senior Research Biochemist, Pharmacology.

Daniel Bollag completed a post-doctoral fellowship at Princeton University, and received his Ph.D. degree in Biochemistry from Cornell University. He earned his B.S. degree in Science and B.A. in French at Pennsylvania State University.

Daniel M. Bollag is the Chief Strategy Officer at Ocular Therapeutix, based in United States, North America. With a background in Biotechnology, Daniel M. Bollag has a rich history of leadership and innovation.Daniel M. Bollag studied Ph.D Biochemistry at Cornell University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.